Health systems are navigating a rapidly changing landscape as innovative, high-cost therapies reshape care delivery and the economics of care. These shifts are creating new opportunities for health systems to move beyond their traditional role at the end of the life sciences value chain and play a more active role upstream.
For executives, the question is no longer whether to engage, but where to play, when to act, and what to build vs. where to partner. The challenge is balancing near-term opportunities with longer-term strategic bets.
Join health system leaders from Duke University Health System, WVU Medicine, University of Chicago Medicine, and Lumicera Health Services, alongside a ZS expert who work across both health systems and life sciences, to hear how they are making these calls, with real examples of building and partnering into new areas and the lessons that followed.
Learnings include:
- What is shifting in the environment to open the door to a larger role for health systems?
- Which upstream opportunities are compelling in the near term versus over the longer term?
- What does it take operationally to turn a promising idea into something scalable and sustainable?
- How should health systems weigh building a capability internally versus partnering?